Advances in the application of insulin resistance-related indicators in the clinical evaluation of metabolic dysfunction-associated steatotic liver disease
Yi Li, Huan Li, Bolun Zhang, Qingming Wu, Hui Long · 2026
Read Advances in the application of insulin resistance-related indicators in the clinical evaluation of metabolic dysfunction-associated steatotic liver disease by Yi Li, Huan Li, Bolun Zhang, Qingming Wu, Hui Long (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13587031.txt.
Description
Yi Li and four co-authors review measures of insulin resistance used to judge fatty liver disease tied to metabolic trouble, in a paper from twenty twenty-six. The disease, now the world's most common chronic liver condition, has insulin resistance at its core. Clinicians use a range of blood-based scores and indices to gauge it without invasive tests.
The review sums up how far each indicator has gotten in clinical assessment, and where each falls short in practice. The authors look ahead to sharper non-invasive markers, models that fuse several layers of biological data, and care tailored to the individual patient. Their aim is better management of the disease and better outcomes for patients.
Catalog record
| CREATOR | Yi Li, Huan Li, Bolun Zhang, Qingming Wu, Hui Long |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |